Clinical Trials Logo

Filter by:
  • Withdrawn  
  • « Prev · Page [8]
NCT ID: NCT00407121 Withdrawn - Clinical trials for Vogt Koyanagi Harada Disease

Intravitreal Bevacizumab for Inflammatory Neovascular Membranes

Start date: December 2006
Phase: Phase 3
Study type: Interventional

Intravitreal injection of Bevacizumab in patients with Neovascular Membranes secondary to intraocular inflammation. We injected a single injection of Bevacizumab (2.5 mg/0.1 ml) and evaluate visual acuity , Fluorescein angiogram and retinal thickness by Optical Coherence Tomography (OCT) in 4 patients with Vogt Koyanagi Harada disease, 1 patient with Serpiginous Choroidopathy and 1 patient with Multifocal Choroiditis.

NCT ID: NCT00407108 Withdrawn - Clinical trials for Diabetic Retinopathy

Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy

Start date: March 2006
Phase: Phase 3
Study type: Interventional

To investigate the feasibility and advantages of using perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting vitrectomy using a dual, dynamic drive (3D)technology. In complicated surgeries in advanced diabetic retinopathy and retinal detachment

NCT ID: NCT00406380 Withdrawn - Telangiectasis Clinical Trials

Effect of Avastin in Juxtafoveal Telangiectasias

Start date: September 2006
Phase: Phase 3
Study type: Interventional

Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients with Yuxtafoveal Telangiectasias

NCT ID: NCT00406172 Withdrawn - Clinical trials for Cystoid Macular Edema

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Start date: November 2006
Phase: Phase 3
Study type: Interventional

To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.

NCT ID: NCT00403702 Withdrawn - Retinal Detachment Clinical Trials

Comparison High-density Silicone Oils in Retinal Detachment

Start date: August 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to compare the safety, intraocular adverse effects and the anatomic and functional outcome with two endotamponade silicone oil after a 3-month in complex inferior retinal re-detachments.

NCT ID: NCT00347711 Withdrawn - Vascular Occlusion Clinical Trials

Bevacizumab and Retinal Vascular Occlusions

Start date: June 2006
Phase: Phase 3
Study type: Interventional

To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.

NCT ID: NCT00347698 Withdrawn - Clinical trials for Diabetic Retinopathy

Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy

Start date: March 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to evaluate the safety and efficacy of 2.5 mg of intravitreal bevacizumab in one eye, versus panretinal photocoagulation in the contralateral eye, for the treatment of patients with untreated symmetric proliferative diabetic retinopathy.

NCT ID: NCT00255268 Withdrawn - Clinical trials for Metastatic Prostate Cancer

CMAB vs IMAB in Metastatic Prostate Cancer

Start date: August 2004
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy, safety and survival of two treatment regimens: Continuous Intermittent Maximum Androgen Blockade, using goserelin and bicalutamide in patients with prostate cancer. Primary endpoint is time to progression. Fifteen patients will be evaluated. QoL evaluation is also included.